Mei Dong

5.1k total citations · 1 hit paper
122 papers, 3.8k citations indexed

About

Mei Dong is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mei Dong has authored 122 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 43 papers in Oncology and 26 papers in Organic Chemistry. Recurrent topics in Mei Dong's work include Cancer Treatment and Pharmacology (31 papers), Microbial Natural Products and Biosynthesis (20 papers) and Synthetic Organic Chemistry Methods (19 papers). Mei Dong is often cited by papers focused on Cancer Treatment and Pharmacology (31 papers), Microbial Natural Products and Biosynthesis (20 papers) and Synthetic Organic Chemistry Methods (19 papers). Mei Dong collaborates with scholars based in China, Japan and Canada. Mei Dong's co-authors include Qing‐Wen Shi, Rui Hai Liu, Xiangjiu He, Hiromasa Kiyota, Yu‐Cheng Gu, Bin Cong, Timothy P. Hughes, Andreas Hochhaus, Neil J. Gallagher and Richard A. Larson and has published in prestigious journals such as New England Journal of Medicine, Chemical Reviews and Advanced Materials.

In The Last Decade

Mei Dong

118 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2010 1.2k citations Mei Dong et al. profile →

Peers

Countries citing papers authored by Mei Dong

Since Specialization

Citations

This map shows the geographic impact of Mei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Dong more than expected).

Fields of papers citing papers by Mei Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Dong. The network helps show where Mei Dong may publish in the future.

Co-authorship network of co-authors of Mei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Dong. A scholar is included among the top collaborators of Mei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Dong. Mei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness analysis of sotorasib plus panitumumab in the treatment of refractory colorectal cancer with mutated KRAS G12C in the USA 2025 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Tong Liu, (unknown), (unknown), (unknown), Mei Dong, Ruihong Yao	0
2	Genetic landscape and prognosis of conjunctival melanoma in Chinese patients 2024 ·British Journal of Ophthalmology ·Hanhan Shi, (unknown), Tianyu Zhu, Jie Chen, (unknown), (unknown), (unknown), Jing Ruan, Shengfang Ge, (unknown), Mei Dong, Renbing Jia, (unknown), (unknown), (unknown)	3
3	Ultrasound diagnosis of a retroperitoneal fetus in fetu: A case report 2023 ·Experimental and Therapeutic Medicine ·(unknown), (unknown), Mei Dong	2
4	A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China 2023 ·Frontiers in Neurology ·Hongxing Li, Mei Dong, Xiaoxiao Peng, Yizhe Liu, Han Wang, Chao Li, (unknown), Kai Zhang, (unknown)	1
5	Efficacy and safety evaluation of albumin-bound paclitaxel chemotherapy in East Asian patients with gynecological tumors based on the degree of paclitaxel binding to patient plasma 2022 ·Anti-Cancer Drugs ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shuai Jiang, Mei Dong	1
6	Biomarkers of related driver genes predict anti-tumor efficacy of immune checkpoint inhibitors 2022 ·Frontiers in Immunology ·Shuai Jiang, (unknown), Xinyu Luo, Can Zhang, Yang Yu, (unknown), (unknown), Ning Shi, Mei Dong	2
7	New protein tyrosine phosphatase inhibitors from fungus Aspergillus gorakhpurensis F07ZB1707 2021 ·RSC Advances ·(unknown), (unknown), (unknown), Tianhui Zhu, (unknown), Yan Fu, (unknown), Ruolan Li, Xuexia Zhang, Mei Dong, Françoise Sauriol, Yu‐Cheng Gu, Qing‐Wen Shi, Xinhua Lu, Zhi‐Yu Ni	6
8	DCMD: Distance-based classification using mixture distributions on microbiome data 2021 ·PLoS Computational Biology ·Konstantin Shestopaloff, Mei Dong, Fan Gao, Wei Xu	3
9	Chemical constituents from the genus Saussurea and their biological activities 2017 ·Heterocyclic Communications ·Ting Zhao, (unknown), (unknown), Man‐Li Zhang, Qing‐Wen Shi, Yu‐Cheng Gu, Mei Dong, Hiromasa Kiyota	29
10	Pancreaticoduodenectomy in a patient with previous left ventricular assist device: a case report with specific emphasis on peri-operative logistics 2017 ·Journal of Surgical Case Reports ·Juan Carlos Mejía, Mei Dong, Okechukwu Ojogho	2
11	Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer 2015 ·Anti-Cancer Drugs ·Jingjing Wang, Yanlin Wu, Mei Dong, Xiaohui He, Ziping Wang, Junling Li, Yan Wang	19
12	The first taxane peroxide from the rooted cuttings of Taxus canadensis 2011 ·Heterocyclic Communications ·(unknown), Man‐Li Zhang, Yu‐Fang Wang, Mei Dong, Chang‐Hong Huo, Françoise Sauriol, Qing‐Wen Shi, Hiromasa Kiyota, Yong Jian Zhang	4
13	Novel Taxa-4(20),12-diene and 2(3→20)Abeotaxane from Needles ofTaxus canadensis 2011 ·Bioscience Biotechnology and Biochemistry ·Zhi‐Yu Ni, Yibing Wu, Man‐Li Zhang, Yu‐Fang Wang, Mei Dong, Françoise Sauriol, Chang‐Hong Huo, Qing‐Wen Shi, Yu‐Cheng Gu, Hiromasa Kiyota, Bin Cong	4
14	Landslide stability analysis on basis of LIDAR data extraction 2010 ·RWTH Publications (RWTH Aachen) ·Hui Hu, Tomás Manuel Fernández-Steeger, Mei Dong, Rafig Azzam	1
15	Chemical Studies on Taxus cuspidata 2010 ·Chemistry & Biodiversity ·Yu‐Fang Wang, Shu‐Hong Yu, Mei Dong, (unknown), Chang‐Hong Huo, Qing‐Wen Shi	12
16	[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. 2008 ·PubMed ·Mei Dong, Feng-yi Feng, Yang Zhang, (unknown), Yajie Wang, Jiwei Liu, Santai Song, Qinghua Zhou, Jun Ren, Shunchang Jiao, Jin Li, Xiuwen Wang, Qiang Chen, Zhehai Wang, Nong Xu, Jifeng Feng	4
17	Three New Taxanes with the 10-Alkoxy Group from the Heartwood ofTaxus cuspidata 2007 ·Bioscience Biotechnology and Biochemistry ·Mei Dong, Man‐Li Zhang, Yu‐Fang Wang, (unknown), (unknown), Qing‐Wen Shi, Bin Cong, Hiromasa Kiyota	4
18	New 14-Hydroxy-taxane and 2α,20-Epoxy-11(15→1)abeotaxane from the Needles ofTaxus canadensis 2007 ·Bioscience Biotechnology and Biochemistry ·Qing‐Wen Shi, Mei Dong, Chang‐Hong Huo, (unknown), (unknown), (unknown), Yu‐Fang Wang, Hiromasa Kiyota	6
19	3-Geranyl-4-hydroxy-5-(3′-methyl-2′-butenyl)benzoic Acid as an Anti-inflammatory Compound fromMyrsine seguinii 1999 ·Bioscience Biotechnology and Biochemistry ·Mei Dong, (unknown), (unknown), Ryozo Iriye, Mitsuru Hirota	18
20	Esophageal pH monitoring and the effect of prepulsid in premature infants with gastroesophageal reflux 1996 ·World Journal of Gastroenterology ·Mei Dong, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact